Copyright
©The Author(s) 2017.
World J Gastrointest Endosc. Apr 16, 2017; 9(4): 177-182
Published online Apr 16, 2017. doi: 10.4253/wjge.v9.i4.177
Published online Apr 16, 2017. doi: 10.4253/wjge.v9.i4.177
Variable | Propofol, n (%) | Crude odds ratio (95%CI) | P value | Adjusted odds ratio1 (95%CI) | P value | |
Adenoma detection | ||||||
Gender | Female | 548 (32.6) | 1.27 (1.03-1.56) | 0.03 | 1.07 (0.84-1.35) | 0.60 |
Male | 326 (35.3) | 1.14 (0.87-1.49) | 0.34 | 1.16 (0.87-1.55) | 0.32 | |
Scope insertion time, mean (SD) | ||||||
Gender | Female | 7.3 (5.0) | 0.96 (0.94-0.97) | < 0.001 | 0.97 (0.95-0.99) | 0.02 |
Male | 6.3 (4.2) | 0.96 (0.60-0.99) | 0.02 | 0.97 (0.93-1.00) | 0.05 |
- Citation: Thirumurthi S, Raju GS, Pande M, Ruiz J, Carlson R, Hagan KB, Lee JH, Ross WA. Does deep sedation with propofol affect adenoma detection rates in average risk screening colonoscopy exams? World J Gastrointest Endosc 2017; 9(4): 177-182
- URL: https://www.wjgnet.com/1948-5190/full/v9/i4/177.htm
- DOI: https://dx.doi.org/10.4253/wjge.v9.i4.177